Basit öğe kaydını göster

dc.contributor.authorAyyildiz T.
dc.contributor.authorKiyici M.
dc.contributor.authorOzkan T.B.
dc.contributor.authorTurker G.
dc.contributor.authorTopal N.B.
dc.contributor.authorIscimend R.
dc.contributor.authorKaya E.
dc.date.accessioned2020-06-21T09:42:57Z
dc.date.available2020-06-21T09:42:57Z
dc.date.issued2015
dc.identifier.issn1309-4483
dc.identifier.urihttps://doi.org/10.5835/jecm.omu.32.02.002
dc.identifier.urihttps://hdl.handle.net/20.500.12712/5223
dc.description.abstractLiver transplantation (LT) is a viable treatment option for end-stage hepatic failure. Uludag University Liver Transplant Center has begun performing liver transplant operations in December 2007 and in this article, we review outcomes of 34 cases of LT performed until August 2010 including 30 cadaveric livers and 4 living donors. We achieved a 24-month survival rate of 84.2% in our center and LT surgeries continue with an acceptable success rate. © 2015 OMU.en_US
dc.language.isoengen_US
dc.publisherOndokuz Mayis Universitesien_US
dc.relation.isversionof10.5835/jecm.omu.32.02.002en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHepatitis Ben_US
dc.subjectLiver cirrhosisen_US
dc.subjectPortal biliopathyen_US
dc.subjectTransplantationen_US
dc.titleExperience of liver transplantation in Uludag University: Preliminary resultsen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume32en_US
dc.identifier.issue2en_US
dc.identifier.startpage55en_US
dc.identifier.endpage57en_US
dc.relation.journalJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster